HEAT BIOLOGICS, INC. RESTRICTED STOCK AGREEMENTRestricted Stock Agreement • January 3rd, 2020 • Heat Biologics, Inc. • Pharmaceutical preparations • Delaware
THIS RESTRICTED STOCK AGREEMENT (the “Agreement”) is made and entered into as of (the “Grant Date”), by and between Heat Biologics, Inc., a Delaware corporation (the “Company”), and _________ (the “Participant”).
January 1, 2020 William Ostrander Vice President of Finance c/o Heat Biologics, Inc.Offer Letter Amendment • January 3rd, 2020 • Heat Biologics, Inc. • Pharmaceutical preparations
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • January 3rd, 2020 • Heat Biologics, Inc. • Pharmaceutical preparations • North Carolina
This Amendment (this “Amendment”) effective as of January 1, 2020 to the Employment Agreement, initially effective as of January 1, 2017 and amended as of June 29, 2017, January 1, 2018 and January 1, 2019 (the “Employment Agreement”), by and between Heat Biologics, Inc. (the “Corporation”) and Jeff T. Hutchins (“Executive”). Capitalized terms used herein without definition shall have the meanings assigned in the Employment Agreement.
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • January 3rd, 2020 • Heat Biologics, Inc. • Pharmaceutical preparations • North Carolina
This Amendment (this “Amendment”) effective as of January 1, 2020 to the Employment Agreement, dated December 18, 2009, as amended on January 1, 2011, January 20, 2014, January 11, 2016, April 1, 2016 and January 1, 2017 (the “Employment Agreement”), by and between Heat Biologics, Inc. (the “Company”) and Jeffrey Wolf (“Executive”). Capitalized terms used herein without definition shall have the meanings assigned in the Employment Agreement.
